PubRank

W Rozenbaum

Author PubWeight™ 135.66‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 1983 43.61
2 Reversible ALS-like disorder in HIV infection. Neurology 2001 2.57
3 Detection of IgG antibodies to lymphadenopathy-associated virus in patients with AIDS or lymphadenopathy syndrome. Lancet 1984 2.56
4 AIDS subacute encephalitis. Identification of HIV-infected cells. Am J Pathol 1987 2.47
5 HIV transmission by oral sex. Lancet 1988 2.27
6 Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy. Blood 2001 1.98
7 Quantification of human immunodeficiency virus type 1 proviral load by a TaqMan real-time PCR assay. J Clin Microbiol 2001 1.97
8 Once-daily combination therapy with emtricitabine, didanosine, and efavirenz in human immunodeficiency virus-infected patients. J Infect Dis 2000 1.78
9 Simplification with abacavir-based triple nucleoside therapy versus continued protease inhibitor-based highly active antiretroviral therapy in HIV-1-infected patients with undetectable plasma HIV-1 RNA. AIDS 2001 1.75
10 T cell receptor gamma/delta+ lymphocyte subsets during HIV infection. Clin Exp Immunol 1989 1.72
11 Antimoniotungstate (HPA 23) treatment of three patients with AIDS and one with prodrome. Lancet 1985 1.70
12 Quantitative analysis of human herpesvirus 8 viral load using a real-time PCR assay. J Clin Microbiol 2000 1.60
13 Effect of indinavir on HIV-related wasting. AIDS 1998 1.59
14 Intravenous methotrexate for primary central nervous system non-Hodgkin's lymphoma in AIDS. AIDS 1997 1.51
15 Macronutrient intake and malabsorption in HIV infection: a comparison with other malabsorptive states. Gut 1997 1.46
16 BMD is reduced in HIV-infected men irrespective of treatment. J Bone Miner Res 2003 1.45
17 Factors of weight loss in patients with HIV and chronic diarrhea. J Acquir Immune Defic Syndr Hum Retrovirol 1998 1.45
18 Cholangiopathy associated with Microsporidia infection of the common bile duct mucosa in a patient with HIV infection. Ann Intern Med 1992 1.41
19 Efficacy and tolerance of intravitreal ganciclovir in cytomegalovirus retinitis in acquired immune deficiency syndrome. Ophthalmology 1991 1.28
20 Diabetes, insulin resistance and dyslipidaemia in lipodystrophic HIV-infected patients on highly active antiretroviral therapy (HAART). Diabetes Metab 1999 1.24
21 Effects of zidovudine in 365 consecutive patients with AIDS or AIDS-related complex. Lancet 1988 1.21
22 Pulmonary cryptococcosis: localized and disseminated infections in 27 patients with AIDS. Clin Infect Dis 1995 1.20
23 Phylogenetic analyses indicate an atypical nurse-to-patient transmission of human immunodeficiency virus type 1. J Virol 2000 1.19
24 Adverse metabolic disorders during highly active antiretroviral treatments (HAART) of HIV disease. Diabetes Metab 1999 1.19
25 Critical analysis of T cell subset and function evaluation in patients with persistent generalized lymphadenopathy in groups at risk for AIDS. Clin Exp Immunol 1984 1.04
26 Foscarnet in the treatment of cytomegalovirus retinitis in acquired immune deficiency syndrome. Ophthalmology 1989 1.03
27 Quantification of Epstein-Barr virus load in peripheral blood of human immunodeficiency virus-infected patients using real-time PCR. J Med Virol 2001 1.01
28 Results of chemotherapy in 30 AIDS patients with symptomatic pulmonary Kaposi's sarcoma. Thorax 1994 1.00
29 Pharmacokinetics of emtricitabine, didanosine and efavirenz administered once-daily for the treatment of HIV-infected adults (pharmacokinetic substudy of the ANRS 091 trial). HIV Med 2004 1.00
30 Is there correlation of T cell proliferative functions and surface marker phenotypes in patients with acquired immune deficiency syndrome or lymphadenopathy syndrome? Clin Exp Immunol 1985 0.99
31 Cytomegalovirus-induced alveolar hemorrhage in patients with AIDS: a new clinical entity? Clin Infect Dis 1996 0.99
32 Multiple opportunistic infection in a male homosexual in France. Lancet 1982 0.97
33 Sexual dysfunction in 156 ambulatory HIV-infected men receiving highly active antiretroviral therapy combinations with and without protease inhibitors. J Acquir Immune Defic Syndr 2002 0.96
34 Monitoring of antibodies against human immunodeficiency virus type 1 p25 core protein as prognostic marker. J Infect Dis 1992 0.95
35 Evidence for changes in adrenal and testicular steroids during HIV infection. J Acquir Immune Defic Syndr 1992 0.93
36 Detection of human Betaherpesvirinae in saliva and urine from immunocompromised and immunocompetent subjects. J Clin Microbiol 1997 0.92
37 Cutaneous local necrosis following interferon injections. Int J Dermatol 1991 0.91
38 Diversity of the V3 region of HIV in Paris, France. AIDS 1993 0.89
39 The VIRGO study: nevirapine, didanosine and stavudine combination therapy in antiretroviral-naive HIV-1-infected adults. Antivir Ther 2000 0.88
40 [Decrease of erythrocyte receptors for the C3b fragment of complement in acquired immunodeficiency syndrome]. Presse Med 1988 0.88
41 Rate of detection of human herpesvirus-6 at different stages of HIV infection. Eur J Clin Microbiol Infect Dis 1995 0.88
42 Interferon beta transduction of peripheral blood lymphocytes from HIV-infected donors increases Th1-type cytokine production and improves the proliferative response to recall antigens. Proc Natl Acad Sci U S A 1997 0.87
43 Acute renal failure induced by foscarnet: 4 cases. Clin Nephrol 1988 0.87
44 Recovery of fat following a switch to nucleoside reverse transcriptase inhibitor-sparing therapy in patients with lipoatrophy: results from the 96-week randomized ANRS 108 NoNuke Trial. HIV Med 2008 0.86
45 The efficacy and safety of zidovudine alone or as cotherapy with acyclovir for the treatment of patients with AIDS and AIDS-related complex: a double-blind randomized trial. European-Australian Collaborative Group. AIDS 1993 0.86
46 Definition and diagnosis of cytomegalovirus colitis in patients infected by human immunodeficiency virus. J Acquir Immune Defic Syndr Hum Retrovirol 1997 0.86
47 N-acetylation genotype and risk of severe reactions to sulphonamides in AIDS patients. Br J Clin Pharmacol 1994 0.85
48 Effect of HAART on health status and hospital costs of severe HIV-infected patients: a modeling approach. HIV Clin Trials 2001 0.85
49 Autoantibodies to phospholipids and to the coagulation proteins in AIDS. Thromb Haemost 1997 0.85
50 [Hepatic necrosis secondary to tienilic acid therapy (author's transl)]. Therapie 1980 0.85
51 Abnormal in vitro proliferation and differentiation of T colony forming cells in AIDS patients and clinically normal male homosexuals. Clin Exp Immunol 1985 0.85
52 Treatment interruption after one year of triple nucleoside analogue therapy for primary HIV infection. AIDS 2001 0.85
53 Two cases of cytomegalovirus infection revealed by hearing loss in HIV-infected patients. Biomed Pharmacother 1997 0.84
54 Abnormal in vitro proliferation and differentiation of T colony-forming cells in patients with lymphadenopathy syndrome. Blood 1986 0.84
55 Production of HIV-1 by human B cells infected in vitro: characterization of an EBV genome-negative B cell line chronically synthetizing a low level of HIV-1 after infection. Virology 1998 0.84
56 Isolation of a new retrovirus in a patient at risk for acquired immunodeficiency syndrome. Antibiot Chemother (1971) 1983 0.83
57 [Neuropathological study of 31 cases of acquired immunodeficiency syndrome]. Rev Neurol (Paris) 1987 0.83
58 Filgrastim to treat neutropenia and support myelosuppressive medication dosing in HIV infection. G-CSF 92105 Study Group. AIDS 1996 0.83
59 Human immunodeficiency virus and infected aneurysm of the abdominal aorta: report of three cases. Ann Vasc Surg 1992 0.83
60 [Piercing and its infectious complications. A public health issue in France]. Presse Med 2000 0.81
61 Autocrine interferon-beta synthesis for gene therapy of HIV infection: increased resistance to HIV-1 in lymphocytes from healthy and HIV-infected individuals. AIDS 1995 0.81
62 AIDS and lymphadenopathy syndrome (LAS) patients display similar abnormal in vitro proliferation and differentiation of T-colony forming cells (T-CFC). Cancer Detect Prev Suppl 1987 0.81
63 Treatment of non-meningeal cryptococcosis in patients with AIDS. Centre d'Informations et de Soins de l'Immunodéficience Humaine de l'Est Parisien. J Infect 1996 0.81
64 Intestinal histoplasmosis in AIDS patients: report of three cases observed in France and review of the literature. Eur J Gastroenterol Hepatol 1995 0.80
65 Decreased expression of the C3b/C4b complement receptor (CR1) in AIDS and AIDS-related syndromes correlates with clinical subpopulations of patients with HIV infection. AIDS 1987 0.80
66 Intestinal microsporidiosis: about clinical characteristics and laboratory diagnosis. J Eukaryot Microbiol 1995 0.80
67 Factors predictive of disease progression and death in AIDS-related Kaposi's sarcoma. HIV Med 2000 0.79
68 Half-dose zidovudine. Lancet 1991 0.79
69 Phase II study of liposomal encapsulated daunorubicin in the treatment of AIDS-associated mucocutaneous Kaposi's sarcoma. AIDS 1996 0.79
70 Rifabutin in combination with clofazimine, isoniazid and ethambutol in the treatment of AIDS patients with infections due to opportunist mycobacteria. Groupe d'Etude et de Traitement des Infections à Mycobacteries Résistantes. Tubercle 1991 0.79
71 Comparison among acquired immune deficiency syndrome patients with and without clinical evidence of cardiac disease. Am J Cardiol 1988 0.78
72 Treatment of refractory diarrhoea in AIDS with acetorphan and octreotide: a randomized crossover study. Eur J Gastroenterol Hepatol 1996 0.78
73 [Effect of socio-occupational category on iterative hemodialysis treatment of advanced chronic renal insufficiency. Results of the DIAPHANE computerized Dialysis Registry cooperative program]. Rev Epidemiol Sante Publique 1983 0.78
74 Lack of HPA-23 antiviral activity in HIV-infected patients without AIDS. AIDS 1989 0.78
75 [A cost-effectiveness analysis of changes in therapeutic strategies in the treatment of HIV since 1996]. Therapie 2002 0.78
76 Thrombotic microangiopathy and cytomegalovirus disease in patients infected with human immunodeficiency virus. Clin Infect Dis 1997 0.78
77 Glutathione S-transferase (GSTM1) null genotype and sulphonamide intolerance in acquired immunodeficiency syndrome. Pharmacogenetics 1997 0.78
78 Long-term outcome and treatment modifications in a prospective cohort of human immunodeficiency virus type 1-infected patients on triple-drug antiretroviral regimens. Triest Cohort Investigators. Clin Infect Dis 2000 0.77
79 Multiple myeloma in an HIV-positive man presenting with primary cutaneous plasmacytomas and spinal cord compression. J Am Acad Dermatol 1998 0.77
80 [Lactic acidosis in HIV infected patients]. Presse Med 1994 0.77
81 Prospective follow-up of 67 indinavir-experienced human immunodeficiency virus-infected and AIDS patients treated with the ritonavir/saquinavir combination. Clin Infect Dis 1999 0.77
82 Differences in androgens of HIV positive patients with and without Kaposi sarcoma. J Clin Pathol 1995 0.77
83 Results of culture form colonoscopically obtained specimens for bacteria and fungi in HIV-infected patients with diarrhea. Gastrointest Endosc 1996 0.76
84 Lymphadenopathy in patients at risk for acquired immunodeficiency syndrome. Histopathology and histochemistry. Arch Pathol Lab Med 1985 0.76
85 [Lesions of the conus medullaris and the cauda equina caused by cytomegalovirus in HIV infection. 7 cases]. Presse Med 1995 0.76
86 Cutaneous lesions due to Acanthamoeba sp in a patient with AIDS. J Eukaryot Microbiol 1996 0.76
87 Prognostic value of blood and bone marrow T-colony-forming cells (T-CFC) in patients with lymphadenopathy syndrome (LAS). Biomed Pharmacother 1988 0.76
88 [Zidovudine efficacy and tolerance in 32 patients with cerebral toxoplasmosis in the acquired immunodeficiency syndrome]. Presse Med 1988 0.76
89 [Human cryptosporidiosis: a propos of 4 cases]. Bull Soc Pathol Exot Filiales 1985 0.76
90 Rifabutin versus placebo in combination with three drugs in the treatment of nontuberculous mycobacterial infection in patients with AIDS. Clin Infect Dis 1996 0.75
91 Effect of interferon alpha on high serum androgen concentrations in HIV positive men with Kaposi's sarcoma. J Clin Pathol 1997 0.75
92 Ribavirin therapy for adenovirus pneumonia in an AIDS patient. Am J Respir Crit Care Med 1997 0.75
93 [Acquired immunodeficiency syndrome in 4 homosexuals]. Presse Med 1983 0.75
94 Is lymphocyte transfer a promising therapeutic approach towards AIDS? Ann Inst Pasteur Immunol 1987 0.75
95 [Psychosocial consequences of HIV infection]. Rev Epidemiol Sante Publique 1988 0.75
96 [Febrile pseudotumor lesion of the arm. Atypical presentation of Shulman syndrome]]. Presse Med 2003 0.75
97 Clinical and bacteriologic impact of rifabutin prophylaxis for Mycobacterium avium complex infection in patients with human immunodeficiency virus infection. Clin Infect Dis 1997 0.75
98 Pericardial effusion and AIDS: benefits of surgical drainage. Eur J Cardiothorac Surg 1998 0.75
99 [Predictive value of the assay of serum anti-p25 antibodies in patients with human immunodeficiency virus (HIV-1) infection]. Ann Med Interne (Paris) 1993 0.75
100 [Hemolytic jaundice related to ingestion of indinavir]. Presse Med 1997 0.75
101 [Society of Nephrology, Computer Technology Commission. Dialysis computer program. VI. - Survival and risk factors]. J Urol Nephrol (Paris) 1979 0.75
102 [Kaposi's sarcoma and AIDS]. Bull Soc Pathol Exot Filiales 1984 0.75
103 Tissue-type plasminogen activator activity in HIV-associated HUS. Nephrol Dial Transplant 1998 0.75
104 [Contribution of immunology to the positive and differential diagnosis of the acquired immunodeficiency syndrome. Immunologic mechanisms of the syndrome]. Bull Acad Natl Med 1984 0.75
105 [Development of an anti-HIV gene therapy based on the antiviral properties of beta interferon]. Transfus Clin Biol 1997 0.75
106 [Problems raised by the treatment of Kaposi's sarcoma in subjects with AIDS]. Bull Soc Pathol Exot Filiales 1984 0.75
107 Stavudine, didanosine and nevirapine in antiretroviral-naive HIV-1-infected patients. Antivir Ther 1999 0.75
108 Vitamin B12 injections in patients treated with zidovudine. AIDS 1990 0.75
109 [Acquired immunodeficiency syndrome "AIDS": limits of the unknown]. Ann Med Interne (Paris) 1984 0.75
110 [Salmonella septicemia in acquired immunodeficiency syndrome]. Presse Med 1985 0.75
111 [Adenovirus and acquired immunodeficiency syndrome/Kaposi sarcoma]. Presse Med 1983 0.75
112 [Risks of transmission of the AIDS virus: preventive approaches in dental medicine]. Inf Dent 1986 0.75
113 Possible correlation between exposure to AIDS risk factors, clinical presentation in AIDS, and subsequent prognosis. Eur J Epidemiol 1989 0.75
114 [Maxillofacial manifestations of acquired immunodeficiency syndrome]. Rev Stomatol Chir Maxillofac 1985 0.75
115 [The concept of therapeutic management: exemplary implementation of antiretroviral treatments]. Presse Med 1998 0.75
116 [Acquired immunodeficiency syndrome and related syndromes. Critical analysis of biological tests of cell-mediated immunity]. Presse Med 1984 0.75
117 Clinical and laboratory findings of disseminated Mycobacterium avium complex infection (DMAC) in a pair matched case-control study. Rev Inst Med Trop Sao Paulo 2000 0.75
118 [AIDS and associated syndromes: clinical manifestations]. Rev Fr Transfus Immunohematol 1984 0.75
119 [Orofacial manifestations of AIDS]. Actual Odontostomatol (Paris) 1986 0.75
120 Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). 1983. Rev Invest Clin 2004 0.75
121 [How to lower HIV infection incidence using public health principles]. Rev Epidemiol Sante Publique 2008 0.75
122 Lenograstim for the treatment of neutropenia in patients receiving ganciclovir for cytomegalovirus infection: a randomised, placebo-controlled trial in AIDS patients. Eur J Haematol 2000 0.75
123 [Plurifocal alveolar pneumonia in a patient with AIDS: disseminated Mycobacterium avium intracellulare infection with difficult diagnosis]. Rev Pneumol Clin 1994 0.75
124 Risk factors for AIDS among homosexual men in a moderate incidence area. Int J Epidemiol 1987 0.75
125 Immune status of AIDS patients in France: relationship with lymphadenopathy associated virus tropism. Ann N Y Acad Sci 1984 0.75
126 Immunological evaluation of acquired immune deficiency syndrome patients in France: preliminary results. Antibiot Chemother (1971) 1983 0.75
127 [Lymphomas and AIDS]. Ann Pathol 1986 0.75
128 [Teratocarcinoma with pericardial extension in an AIDS patient]. Presse Med 1994 0.75
129 Cerebral toxoplasmosis in AIDS: a simple laboratory technique for diagnosis. Trans R Soc Trop Med Hyg 1984 0.75
130 [Anasarca caused by exudative enteropathy due to digestive Kaposi's sarcoma]. Presse Med 1989 0.75
131 Primary cardiac lymphoma in patients with AIDS. Ann Med Interne (Paris) 1995 0.75
132 Production of a tac inhibitory activity by adherent cells of HIV-infected subjects at different clinical stages. J Acquir Immune Defic Syndr 1991 0.75
133 [Clinical examination and principles of the symptomatic treatment of severe infectious diarrhea in the adult]. Rev Prat 1982 0.75
134 [Parasitic and fungal diseases in AIDS (excluding pneumocystosis)]. Rev Prat 1986 0.75
135 [Giant esophageal ulcer in a cytomegalovirus infection in a patient with the acquired immunodeficiency syndrome]. Gastroenterol Clin Biol 1985 0.75
136 Stavudine plus didanosine and nevirapine in antiretroviral-naive HIV-infected adults: preliminary safety and efficacy results. VIRGO Study Team. Antivir Ther 1998 0.75
137 Risk factors for A.I.D.S. among homosexual men in France. Eur J Epidemiol 1988 0.75
138 Etiology and management of toxic megacolon in patients with human immunodeficiency virus infection. Gastroenterology 1994 0.75